555 related articles for article (PubMed ID: 34496349)
1. RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.
Wang J; Fu Q; Yang J; Liu JL; Hou SM; Huang X; Cao JS; Liu TL; Wang KZ
Aging (Albany NY); 2021 Sep; 13(17):21134-21141. PubMed ID: 34496349
[TBL] [Abstract][Full Text] [Related]
2. The N6-methyladenosine demethylase FTO is required for odontoblast differentiation in vitro and dentine formation in mice by promoting RUNX2 exon 5 inclusion through RBM4.
Xu M; Li B; Huang J; Jia R; Guo J
Int Endod J; 2023 Dec; 56(12):1534-1549. PubMed ID: 37698901
[TBL] [Abstract][Full Text] [Related]
3. The m
Chen LS; Zhang M; Chen P; Xiong XF; Liu PQ; Wang HB; Wang JJ; Shen J
Acta Pharmacol Sin; 2022 May; 43(5):1311-1323. PubMed ID: 34462564
[TBL] [Abstract][Full Text] [Related]
4. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
[TBL] [Abstract][Full Text] [Related]
5. Mijiao formula regulates NAT10-mediated Runx2 mRNA ac4C modification to promote bone marrow mesenchymal stem cell osteogenic differentiation and improve osteoporosis in ovariectomized rats.
Xiao D; Huang S; Tang Z; Liu M; Di D; Ma Y; Li Y; Duan JA; Lu C; Zhao M
J Ethnopharmacol; 2024 Aug; 330():118191. PubMed ID: 38621468
[TBL] [Abstract][Full Text] [Related]
6. METTL14 Regulates Osteogenesis of Bone Marrow Mesenchymal Stem Cells via Inducing Autophagy Through m6A/IGF2BPs/Beclin-1 Signal Axis.
He M; Lei H; He X; Liu Y; Wang A; Ren Z; Liu X; Yan G; Wang W; Wang Y; Li G; Wang T; Pu J; Shen Z; Wang Y; Xie J; Du W; Yuan Y; Yang L
Stem Cells Transl Med; 2022 Sep; 11(9):987-1001. PubMed ID: 35980318
[TBL] [Abstract][Full Text] [Related]
7. N6-methyladenosine demethylase FTO impairs hepatic ischemia-reperfusion injury via inhibiting Drp1-mediated mitochondrial fragmentation.
Du YD; Guo WY; Han CH; Wang Y; Chen XS; Li DW; Liu JL; Zhang M; Zhu N; Wang X
Cell Death Dis; 2021 May; 12(5):442. PubMed ID: 33947842
[TBL] [Abstract][Full Text] [Related]
8. The GDF11-FTO-PPARγ axis controls the shift of osteoporotic MSC fate to adipocyte and inhibits bone formation during osteoporosis.
Shen GS; Zhou HB; Zhang H; Chen B; Liu ZP; Yuan Y; Zhou XZ; Xu YJ
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3644-3654. PubMed ID: 30279140
[TBL] [Abstract][Full Text] [Related]
9. Inokosterone activates the BMP2 to promote the osteogenic differentiation of bone marrow mesenchymal stem cells and improve bone loss in ovariectomized rats.
Chen Q; Yang Z; Sun X; Long R; Shen J; Wang Z
Biochem Biophys Res Commun; 2023 Nov; 682():349-358. PubMed ID: 37839103
[TBL] [Abstract][Full Text] [Related]
10. METTL3 potentiates osteogenic differentiation of bone marrow mesenchymal stem cells via IGF2BP1/m6A/RUNX2.
Zhou S; Zhang G; Wang K; Yang Z; Tan Y
Oral Dis; 2024 Apr; 30(3):1313-1321. PubMed ID: 36705430
[TBL] [Abstract][Full Text] [Related]
11. METTL14 upregulates TCF1 through m6A mRNA methylation to stimulate osteogenic activity in osteoporosis.
Wang X; Zou C; Li M; Hou C; Jiang W; Bian Z; Zhu L
Hum Cell; 2023 Jan; 36(1):178-194. PubMed ID: 36401086
[TBL] [Abstract][Full Text] [Related]
12. Demethylase FTO promotes mechanical stress induced osteogenic differentiation of BMSCs with up-regulation of HIF-1α.
Sun R; Zhang C; Liu Y; Chen Z; Liu W; Yang F; Zeng F; Guo Q
Mol Biol Rep; 2022 Apr; 49(4):2777-2784. PubMed ID: 35006515
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.
Song W; Yang K; Luo J; Gao Z; Gao Y
Aging (Albany NY); 2021 Jan; 13(3):3909-3925. PubMed ID: 33461172
[TBL] [Abstract][Full Text] [Related]
14. N6-Methyladenosine Demethylase FTO (Fat Mass and Obesity-Associated Protein) as a Novel Mediator of Statin Effects in Human Endothelial Cells.
Mo W; Chen Z; Zhang X; Dai G; Ma D; Pan J; Zhang X; Wu G; Fan W
Arterioscler Thromb Vasc Biol; 2022 May; 42(5):644-658. PubMed ID: 35296150
[TBL] [Abstract][Full Text] [Related]
15. Increased N6-methyladenosine causes infertility is associated with FTO expression.
Ding C; Zou Q; Ding J; Ling M; Wang W; Li H; Huang B
J Cell Physiol; 2018 Sep; 233(9):7055-7066. PubMed ID: 29384212
[TBL] [Abstract][Full Text] [Related]
16. The tumor-suppressive effects of alpha-ketoglutarate-dependent dioxygenase FTO via N6-methyladenosine RNA methylation on bladder cancer patients.
Yi W; Yu Y; Li Y; Yang J; Gao S; Xu L
Bioengineered; 2021 Dec; 12(1):5323-5333. PubMed ID: 34499008
[TBL] [Abstract][Full Text] [Related]
17. Dynamic m6A modification regulates local translation of mRNA in axons.
Yu J; Chen M; Huang H; Zhu J; Song H; Zhu J; Park J; Ji SJ
Nucleic Acids Res; 2018 Feb; 46(3):1412-1423. PubMed ID: 29186567
[TBL] [Abstract][Full Text] [Related]
18. KDM5A controls bone morphogenic protein 2-induced osteogenic differentiation of bone mesenchymal stem cells during osteoporosis.
Wang C; Wang J; Li J; Hu G; Shan S; Li Q; Zhang X
Cell Death Dis; 2016 Aug; 7(8):e2335. PubMed ID: 27512956
[TBL] [Abstract][Full Text] [Related]
19. N6-methyladenosine Demethylase FTO Induces the Dysfunctions of Ovarian Granulosa Cells by Upregulating Flotillin 2.
Zhou L; Han X; Li W; Wang N; Yao L; Zhao Y; Zhang L
Reprod Sci; 2022 Apr; 29(4):1305-1315. PubMed ID: 34254281
[TBL] [Abstract][Full Text] [Related]
20. The m6A mRNA demethylase FTO in granulosa cells retards FOS-dependent ovarian aging.
Jiang ZX; Wang YN; Li ZY; Dai ZH; He Y; Chu K; Gu JY; Ji YX; Sun NX; Yang F; Li W
Cell Death Dis; 2021 Jul; 12(8):744. PubMed ID: 34315853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]